Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
80.46
+3.59 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
78.86
-1.60 (-1.99%)
After-hours: Mar 9, 2026, 7:06 PM EDT
Bright Minds Biosciences Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Net Income | -19.84 | -12.23 | -2.8 | -7.37 | -14.96 | -8.65 | |
| Depreciation & Amortization | 0.08 | 0.08 | 0.07 | 0.07 | 0.01 | - | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 0 | - | |
| Stock-Based Compensation | 4.29 | 3.18 | 0.84 | 1.15 | 0.9 | 0.88 | |
| Other Operating Activities | 2.79 | -0.28 | -0 | 0.07 | -0.26 | 0.14 | |
| Change in Accounts Payable | 1.03 | 1.69 | 0.24 | -1.2 | 0.77 | 0.51 | |
| Change in Other Net Operating Assets | -1.35 | -1.13 | -0.2 | 0.26 | -0.04 | -0.2 | |
| Operating Cash Flow | -13.01 | -8.69 | -1.85 | -7.02 | -13.59 | -7.32 | |
| Long-Term Debt Repaid | - | -0.1 | -0.09 | -0.09 | -0.01 | - | |
| Net Debt Issued (Repaid) | -0.1 | -0.1 | -0.09 | -0.09 | -0.01 | - | |
| Issuance of Common Stock | 50.42 | 86.03 | 0.9 | 1.47 | 6 | 27.84 | |
| Other Financing Activities | -3.4 | -0.36 | - | 0.8 | -0.8 | -1.79 | |
| Financing Cash Flow | 46.92 | 85.57 | 0.81 | 2.19 | 5.2 | 26.06 | |
| Foreign Exchange Rate Adjustments | -2.75 | 0.31 | 0.01 | -0.05 | 0.26 | 0.22 | |
| Net Cash Flow | 31.15 | 77.19 | -1.03 | -4.88 | -8.13 | 18.96 | |
| Levered Free Cash Flow | -7.7 | -4.6 | -0.69 | -4.22 | -7.58 | -3.85 | |
| Unlevered Free Cash Flow | -7.67 | -4.58 | -0.69 | -4.22 | -7.58 | -3.85 | |
| Change in Working Capital | -0.32 | 0.55 | 0.04 | -0.94 | 0.72 | 0.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.